US Medicare Broadens Coverage For Lung Cancer Screening With Low-Dose CT
Executive Summary
US Medicare has expanded eligibility for lung cancer screenings by lowering age and smoking history requirements. The agency’s final decision aims to catch the disease early.
You may also be interested in...
Chinese Scientists Claim Blood Test Catches Lung Cancer Early
Researchers in China may have developed a new diagnostic for detecting lung cancer in the blood. A Peking University study found its new assay was 90% accurate in finding early-stage disease.
Alarming Rise Of Diabetes in Several US States, Study Shows
A study of diabetes rates across the US over four years reveals significant increases in the disease in many states. Tobias Oerum, diabetes advocate and cofounder of the company that conducted the study, discussed the data and some of the factors contributing to this troubling trend with Medtech Insight.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.